Welcome to Jarir!
Item 1 of 1
Item 1 of 1
LAP Lambert Academic Publishing
Chimeric Vaccine Design Against Melioidosis via Subtractive Proteomics
SR 272
Inclusive of VAT
SR16Per Month/24 months
This book is printed on demand and is non-refundable after purchase
Available Formats :
Printed Book
It will be sent to your address
SR272
Incl. VAT
Secure Shopping
Convenient Returns
Genuine & Warranted
Fast Delivery
Or
About this Product
Subtractive proteomics and reverse vaccinology were employed to design a chimeric multi-epitope vaccine against melioidosis, a severe infectious disease caused by the multidrug-resistant bacterium, Burkholderia pseudomallei. From 21 non-redundant pathogen proteomes, four proteins were selected as vaccine candidates based on essentiality, virulence, non-homology to humans, structural availability, subcellular localization, and antigenicity. The major histocompatibility complex class I, II, and B-cell epitopes were predicted and evaluated for immunogenicity, solubility, allergenicity, and hydrophilicity. A chimeric vaccine was constructed using the epitopes, adjuvants, linkers, and PADRE sequences. Docking and molecular dynamics simulations confirmed interactions between HLA alleles and TLR4, indicating the potential to elicit an immune response, demonstrating the utility of computational tools in developing vaccines against B. pseudomallei.
Report an issue with this product.
